Hall R A, Brand T N, Lobigs M, Sangster M Y, Howard M J, Mackenzie J S
Department of Microbiology, University of Western Australia, Nedlands, Australia.
J Gen Virol. 1996 Jun;77 ( Pt 6):1287-94. doi: 10.1099/0022-1317-77-6-1287.
The lack of an effective animal model has been a major obstacle in attempts to define the role of humoral and cellular immune responses in protection against flavivirus infection. We have used F1 hybrid mice (BALB/c x C3H/RV) that are heterozygous for the flavivirus resistance allele F1vr and show reduced virus replication in the brain after intracerebral inoculation. F1 hybrid mice challenged by intracerebral inoculation with Murray Valley encephalitis (MVE) virus developed encephalitis 2-3 days later than a genetically susceptible strain (BALB/c) but showed a similar mortality rate. This delay in the onset of disease provided more opportunity for virus clearance by primed immune responses. Using F1 hybrid mice we were able to demonstrate protective immunity induced by structural and non-structural proteins of MVE virus by immunization with pure NS1 protein or recombinant vaccinia viruses that expressed various regions of the MVE genome. These constructs included VV-STR (C-prM-E-NS1-NS2A), VV-delta C (prM-E-Ns1-NS2A) and VV-NS1 (NS1-NS2A). VV-delta C vaccinated mice were completely protected (100% survival)from challenge with 1000 infectious units of MVE virus, while mice inoculated with VV-STR, VV-NS1 or pure NS1 were partially protected (40%, 47% and 85% respectively). Analysis of prechallenge sera and in vivo depletion studies revealed that the solid protection induced by VV-delta C was mediated by neutralizing antibody to the E protein and did not require a CD8+ T cell response. The partial protection provided by VV-STR, VV-NS1 and pure NS1 occurred after induction of antibody to NS1. However, depletion of CD8+ cells prior to virus challenge ablated the protection provided by VV-NS1 indicating some requirement for class I restricted cytotoxic T cells.
缺乏有效的动物模型一直是试图确定体液免疫和细胞免疫反应在抗黄病毒感染保护作用中所起作用的主要障碍。我们使用了F1杂种小鼠(BALB/c×C3H/RV),它们对于黄病毒抗性等位基因F1vr是杂合的,并且在脑内接种后在脑中显示出病毒复制减少。脑内接种墨累谷脑炎(MVE)病毒攻击的F1杂种小鼠比遗传易感品系(BALB/c)晚2-3天发生脑炎,但显示出相似的死亡率。疾病发作的这种延迟为引发的免疫反应清除病毒提供了更多机会。使用F1杂种小鼠,我们能够通过用纯NS1蛋白或表达MVE基因组各个区域的重组痘苗病毒免疫,证明MVE病毒的结构和非结构蛋白诱导的保护性免疫。这些构建体包括VV-STR(C-prM-E-NS1-NS2A)、VV-delta C(prM-E-Ns1-NS2A)和VV-NS1(NS1-NS2A)。用VV-delta C接种的小鼠在用1000个感染单位的MVE病毒攻击后得到完全保护(100%存活),而接种VV-STR、VV-NS1或纯NS1的小鼠得到部分保护(分别为40%、47%和85%)。攻击前血清分析和体内清除研究表明,VV-delta C诱导的完全保护是由针对E蛋白的中和抗体介导的,并且不需要CD8+T细胞反应。VV-STR、VV-NS1和纯NS1提供的部分保护在诱导针对NS1的抗体后发生。然而,在病毒攻击前清除CD8+细胞消除了VV-NS1提供的保护,表明对I类限制性细胞毒性T细胞有一定需求。